• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Incorrect Or Inadequate Test Results (2456); High Test Results (2457)
Patient Problems Transient Ischemic Attack (2109); Confusion/ Disorientation (2553)
Event Date 11/09/2015
Event Type  Injury  
Manufacturer Narrative
Investigation is pending.
 
Event Description
The caller alleged a variance between the inratio inr result and the laboratory inr result.On (b)(6) 2015 at 10:47am, the caller tested on the inratio device and her inr was 2.2.The caller's therapeutic range was 2.5 - 3.5.She takes her warfarin in the evening and had taken her normal dose the night before.On (b)(6) 2015 at 11:59 am, the caller's inratio inr was 2.3.The caller was driving with her daughter when she experienced confusing speech and was admitted to hospital.Her daily warfarin had not yet been taken.The laboratory inr at 12:30pm was 1.4.A computerized tomography (ct scan) was performed and the caller was diagnosed with a transient ischemic attack (tia).Treatment included a heparin drip and oral coumadin.On (b)(6) 2014, the caller was discharged from the hospital with an laboratory inr of 2.5.Warfarin dose was 5mg 5 days and 2.5mg 2 days.On (b)(6) 2015, the caller followed up with her physician however no laboratory inr was performed.On (b)(6) 2015 at 9:55 am, the inratio inr was 2.3.The warfarin dose was 5mg 6 days and 2.5mg 1 day.There was no additional information provided.
 
Manufacturer Narrative
It is indicated that the product is not returning for evaluation.Therefore, a review of the testing history on lot 373678a was performed and met release criteria.The product performed as expected.A review of the manufacturing records for lot 373678a did not uncover any non-conformances and the lot met release specification.The customer reported a history of skin cancer, colon cancer and colitis.These conditions may impact the performance of the assay.An improper technique was identified in the complaint.This cannot be ruled out as a cause for the unexpected results.Based on the information available, there is no indication of a product deficiency and no corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer (Section G)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5278413
MDR Text Key33052387
Report Number2027969-2015-00995
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 11/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number373678A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/22/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
OTHER UNSPECIFIED MEDICATIONS
Patient Outcome(s) Hospitalization; Required Intervention;
-
-